Association of the plasma platelet-derived microparticles to platelet count ratio with hospital mortality and disseminated intravascular coagulopathy in critically ill patients

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 8, 2015, Pages 773-782

  Ohuchi, Masatsugu ^a   Fujino, Kazunori ^a   Kishimoto, Takuma ^a   Yamane, Tetsunobu ^a   Hamamoto, Tetsu ^a   Tabata, Takahisa ^a   Tsujita, Yasuyuki ^a   Matsushita, Mikiko ^a   Takahashi, Kan ^a   Matsumura, Kazuhiro ^a   Eguchi, Yutaka ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Acute physiology and chronic health evaluation II score; Microparticle; Mortality; Sequential organ failure assessment score; The Japanese association for acute medicine disseminated intravascular coagulopathy score

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PLATELET MICROPARTICLE; PROSPECTIVE STUDY; RATIO OF PLATELET DERIVED MICROPARTICLE TO PLATELET; SURVIVOR; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; BLOOD; COHORT ANALYSIS; CRITICAL ILLNESS; HOSPITAL MORTALITY; MEMBRANE MICROPARTICLE; MIDDLE AGED; PHYSIOLOGY; PREDICTIVE VALUE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CELL-DERIVED MICROPARTICLES; COHORT STUDIES; CRITICAL ILLNESS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 84938890360     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.29439     Document Type: Article

References (39)

1. Levi M, Keller TT, van Gorp E, ten Cate H: Infection microparticles: pathophysiology and clinical implications. Blood Rev, 2007; 21: 157-171.
2. Nomura S, Ozaki Y, Ikeda Y: Function and role of microparticles in various clinical settings. Thromb Res, 2008; 123: 8-23.
3. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI: Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost, 2007; 97: 425-434.
4. Italiano JE, Mairuhu AT, Flaumenhaft R: Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol, 2010; 17: 578-584.
5. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y: Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost, 2003; 89: 506-512.
6. Nomura S, Imamura A, Okuno M, Kamiyama Y, Fujimura Y, Ikeda Y, Fukuhara S: Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines. Thromb Res, 2000; 98: 257-268.
7. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol, 2000; 121: 437-443.
8. Andoh A, Tsujikawa T, Hata K, Araki Y, Kitoh K, Sasaki M, Yoshida T, Fujiyama Y: Elevated circulating plateletderived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol, 2005; 100: 2042-2048.
9. Schouten M, Wiersinga WJ, Levi M, van der Poll T: Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol, 2008; 83: 536-545.
10. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood, 2000; 95: 930-935.
11. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A: Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost, 2001; 85: 810-820.
12. Perez-Casal M, Thompson V, Downey C, Welters I, Wyncoll D, Thachil J, Toh CH: The clinical and functional relevance of microparticles induced by activated protein C microparticles: pathophysiology and clinical implications. Blood Rev, 2007; 21: 157-171.
13. Nomura S, Ozaki Y, Ikeda Y: Function and role of microparticles in various clinical settings. Thromb Res, 2008; 123: 8-23.
14. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI: Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost, 2007; 97: 425-434.
15. Italiano JE, Jr., Mairuhu AT, Flaumenhaft R: Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol, 2010; 17: 578-584.
16. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y: Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost, 2003; 89: 506-512.
17. Nomura S, Imamura A, Okuno M, Kamiyama Y, Fujimura Y, Ikeda Y, Fukuhara S: Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines. Thromb Res, 2000; 98: 257-268.
18. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol, 2000; 121: 437-443.
19. Andoh A, Tsujikawa T, Hata K, Araki Y, Kitoh K, Sasaki M, Yoshida T, Fujiyama Y: Elevated circulating plateletderived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol, 2005; 100: 2042-2048.
20. Schouten M, Wiersinga WJ, Levi M, van der Poll T: Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol, 2008; 83: 536-545.
21. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood, 2000; 95: 930-935.
22. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A: Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost, 2001; 85: 810-820.
23. Perez-Casal M, Thompson V, Downey C, Welters I, Wyncoll D, Thachil J, Toh CH: The clinical and functional relevance of microparticles induced by activated protein C etry assay. Scand J Clin Lab Invest, 2013; 73: 229-239.
24. Stravitz RT, Bowling R, Bradford RL, Key NS, Glover S, Thacker LR, Gabriel DA: Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology, 2013; 58: 304-313.
25. Agarwal B, Wright G, Gatt A, Riddell A, Vemala V, Mallett S, Chowdary P, Davenport A, Jalan R, Burroughs A: Evaluation of coagulation abnormalities in acute liver failure. J Hepatol, 2012; 57: 780-786.
26. Franca CN, Pinheiro LF, Izar MC, Brunialti MK, Salomao R, Bianco HT, Kasmas SH, Barbosa SP, de Nucci G, Fonseca FA: Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J, 2012; 76: 729-736.
27. Jy W, Horstman LL, Ahn YS: Microparticle size and its relation to composition, functional activity, and clinical significance. Semin Thromb Hemost, 2010; 36: 876-880.
28. Nomura S, Shouzu A, Taomoto K, Togane Y, Goto S, Ozaki Y, Uchiyama S, Ikeda Y: Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb, 2009; 16: 878-887.
29. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H: Thrombocytopenia and prognosis in intensive care. Crit Care Med, 2000; 28: 1871-1876.
30. Wang T, Liu Z, Wang Z, Duan M, Li G, Wang S, Li W, Zhu Z, Wei Y, Christiani DC, Li A, Zhu X: Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One, 2014; 9: e94124.
31. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM: Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung, 2010; 39: 21-26.
32. Ueba T, Nomura S, Inami N, Nishikawa T, Kajiwara M, Iwata R, Yamashita K: Correlation and association of plasma interleukin-6 and plasma platelet-derived microparticles, markers of activated platelets, in healthy individuals. Thromb Res, 2010: 125: e329-e334.
33. Ueba T, Nomura S, Inami N, Nishikawa T, Kajiwara M, Iwata R, Yamashita K: Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb, 2010; 17: 342-349.
34. Seo JW, Kim HK, Kim JE, Park S, Cho HI: Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation. Thromb Res, 2009; 123: 565-572.
35. Exner T, Joseph J, Low J, Connor D, Ma D: A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis, 2003; 14: 773-779.
36. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs- Mecarelli L: Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int, 2006; 69: 1416-1423.
37. Shirafuji T, Hamaguchi H, Higuchi M, Kanda F: Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients. Muscle Nerve, 2009; 39: 586-590.
38. van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R: P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem, 2006; 52: 657-664.
39. Ohuchi M, Hashimoto K, Ushiba A, Kishimoto T, Hamamoto T, Tabata T, Tsujita Y, Matsushita M, Takahashi K, Matsumura K, Fujino K, Eguchi Y: Plasma platelet- derived microparticles to platelet count ratio as a marker of mortality in critically ill patients. Crit Care, 2014; 18(Suppl 1): P210